255 related articles for article (PubMed ID: 33491714)
1. Radiolabelling of nanomaterials for medical imaging and therapy.
Pellico J; Gawne PJ; T M de Rosales R
Chem Soc Rev; 2021 Mar; 50(5):3355-3423. PubMed ID: 33491714
[TBL] [Abstract][Full Text] [Related]
2. Radiolabelling of Extracellular Vesicles for PET and SPECT imaging.
Khan AA; T M de Rosales R
Nanotheranostics; 2021; 5(3):256-274. PubMed ID: 33654653
[TBL] [Abstract][Full Text] [Related]
3. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
Farzin L; Sheibani S; Moassesi ME; Shamsipur M
J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
[TBL] [Abstract][Full Text] [Related]
4. Nuclear imaging approaches facilitating nanomedicine translation.
Pérez-Medina C; Teunissen AJP; Kluza E; Mulder WJM; van der Meel R
Adv Drug Deliv Rev; 2020; 154-155():123-141. PubMed ID: 32721459
[TBL] [Abstract][Full Text] [Related]
5. Direct Cell Radiolabeling for
Gawne PJ; Man F; Blower PJ; T M de Rosales R
Chem Rev; 2022 Jun; 122(11):10266-10318. PubMed ID: 35549242
[TBL] [Abstract][Full Text] [Related]
6. PAMAM Dendrimer-Based Nanodevices for Nuclear Medicine Applications.
Xiao T; Li D; Shi X; Shen M
Macromol Biosci; 2020 Feb; 20(2):e1900282. PubMed ID: 31829523
[TBL] [Abstract][Full Text] [Related]
7. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.
Man F; Gawne PJ; T M de Rosales R
Adv Drug Deliv Rev; 2019 Mar; 143():134-160. PubMed ID: 31170428
[TBL] [Abstract][Full Text] [Related]
8. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
[TBL] [Abstract][Full Text] [Related]
9. Inorganic nanomedicines and their labeling for biological imaging.
Kim KM; Kang JH; Vinu A; Choy JH; Oh JM
Curr Top Med Chem; 2013; 13(4):488-503. PubMed ID: 23432011
[TBL] [Abstract][Full Text] [Related]
10. Development of peptide and protein based radiopharmaceuticals.
Wynendaele E; Bracke N; Stalmans S; De Spiegeleer B
Curr Pharm Des; 2014; 20(14):2250-67. PubMed ID: 24025103
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicines for Renal Management: From Imaging to Treatment.
Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
[TBL] [Abstract][Full Text] [Related]
12. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis.
Wuest M; Perreault A; Richter S; Knight JC; Wuest F
Apoptosis; 2019 Apr; 24(3-4):221-244. PubMed ID: 30684144
[TBL] [Abstract][Full Text] [Related]
13. Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals.
Morais M; Ma MT
Drug Discov Today Technol; 2018 Dec; 30():91-104. PubMed ID: 30553525
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles labeled with gamma-emitting radioisotopes: an attractive approach for in vivo tracking using SPECT imaging.
Ahmadi M; Emzhik M; Mosayebnia M
Drug Deliv Transl Res; 2023 Jun; 13(6):1546-1583. PubMed ID: 36811810
[TBL] [Abstract][Full Text] [Related]
15. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
Goins B; Bao A; Phillips WT
Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
[TBL] [Abstract][Full Text] [Related]
16. Methods for Radiolabelling Nanoparticles: SPECT Use (Part 1).
Varani M; Bentivoglio V; Lauri C; Ranieri D; Signore A
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291729
[TBL] [Abstract][Full Text] [Related]
17. Recent Progress in Technetium-99m-Labeled Nanoparticles for Molecular Imaging and Cancer Therapy.
Mushtaq S; Bibi A; Park JE; Jeon J
Nanomaterials (Basel); 2021 Nov; 11(11):. PubMed ID: 34835786
[TBL] [Abstract][Full Text] [Related]
18. Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.
Edmonds S; Volpe A; Shmeeda H; Parente-Pereira AC; Radia R; Baguña-Torres J; Szanda I; Severin GW; Livieratos L; Blower PJ; Maher J; Fruhwirth GO; Gabizon A; T M de Rosales R
ACS Nano; 2016 Nov; 10(11):10294-10307. PubMed ID: 27781436
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional Radionuclides.
Carter LM; Kesner AL; Pratt EC; Sanders VA; Massicano AVF; Cutler CS; Lapi SE; Lewis JS
Mol Imaging Biol; 2020 Feb; 22(1):73-84. PubMed ID: 31001765
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeling nanomaterials for multimodality imaging: New insights into nuclear medicine and cancer diagnosis.
Ge J; Zhang Q; Zeng J; Gu Z; Gao M
Biomaterials; 2020 Jan; 228():119553. PubMed ID: 31689672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
